Anaptysbio (ANAB) EBIT Margin Growth (3y) (2019 - 2026)
Anaptysbio (ANAB) EBIT Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 7,794.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Anaptysbio | 1.55 Bn | 1.27 Bn | - | 309,598.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 309,598.00 |
| Dec 31, 2025 | 60,866.00 |
| Sep 30, 2025 | 236,121.00 |
| Jun 30, 2025 | 216,855.00 |
| Mar 31, 2025 | 317,393.00 |
| Dec 31, 2024 | 304,312.00 |
| Sep 30, 2024 | -11,790.00 |
| Jun 30, 2024 | -36,486.00 |
| Mar 31, 2024 | -40,423.00 |
| Dec 31, 2023 | -52,348.00 |
| Mar 31, 2023 | -302,645.00 |
| Dec 31, 2022 | 22,247.00 |
| Jun 30, 2022 | -175,296.00 |
| Sep 30, 2021 | 30,392.00 |
| Dec 31, 2020 | 29,394.00 |
| Dec 31, 2019 | -42,453.00 |
| Jun 30, 2019 | -59,222.00 |